Related Experiment Videos
[Circulating anticoagulant and open heart surgery (author's transl)]
Anesthesie, Analgesie, Reanimation
|January 1, 1981
Summary
Managing patients with mitral cardiopathy and circulating anticoagulants requires careful heparin administration due to high risks of thromboembolic events or severe bleeding.
Area of Science:
- Cardiology
- Hematology
Context:
- Mitral cardiopathy presents complex challenges for surgical intervention.
- Patients with circulating anticoagulants require specialized management during cardiopulmonary bypass.
Purpose:
- To highlight the risks and management difficulties of heparin administration in patients with mitral cardiopathy and circulating anticoagulants.
Summary:
- Two patients with mitral cardiopathy underwent valve replacement under cardiopulmonary bypass despite having circulating anticoagulants.
- Increased heparin doses were administered under strict monitoring, but both patients experienced fatal outcomes: one from coronary thrombosis, the other from severe bleeding and thrombosis.
Impact:
- This case underscores the significant risks and challenges in adapting and controlling heparin therapy for such high-risk patients.
- Emphasizes the critical need for heightened awareness and meticulous management strategies in similar clinical scenarios.